Smoking, inflammatory patterns and postprandial hypertriglyceridemia

Atherosclerosis

Volumn 203, Issue 2, 2009, Pages 633-639

  Kabagambe, Edmond K ^a   Ordovas, Jose M ^b   Tsai, Michael Y ^c   Borecki, Ingrid B ^d   Hopkins, Paul N ^e   Glasser, Stephen P ^f   Arnett, Donna K ^a  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b TUFTS UNIVERSITY   (United States)

^c UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^d WASHINGTON UNIVERSITY   (United States)

^e UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^f University of Alabama at Birmingham   (United States)

Author keywords

Inflammation; Insulin resistance; Lipids; Smoking; Triglycerides

Indexed keywords

ANTILIPEMIC AGENT; C REACTIVE PROTEIN; FENOFIBRATE; INTERLEUKIN 2 RECEPTOR ALPHA; INTERLEUKIN 6; MONOCYTE CHEMOTACTIC PROTEIN 1; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ARTICLE; BODY FAT; CIGARETTE SMOKING; CONTROLLED STUDY; DISEASE ASSOCIATION; DRUG WITHDRAWAL; FEMALE; HUMAN; HYPERTRIGLYCERIDEMIA; INFLAMMATION; INSULIN RESISTANCE; LIPID DIET; LIPID METABOLISM; MAJOR CLINICAL STUDY; MALE; POSTPRANDIAL STATE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; TRIACYLGLYCEROL BLOOD LEVEL;

ADULT; AGED; DIETARY FATS; FEMALE; HUMANS; HYPERTRIGLYCERIDEMIA; INFLAMMATION; INSULIN RESISTANCE; LIGANDS; MALE; MIDDLE AGED; OXIDATIVE STRESS; PEROXISOME PROLIFERATOR-ACTIVATED RECEPTORS; PHENOTYPE; POSTPRANDIAL PERIOD; SMOKING; TRIGLYCERIDES;

EID: 62649171648     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2008.08.005     Document Type: Article

References (27)

1. Sharrett A.R., Heiss G., Chambless L.E., et al. Metabolic and lifestyle determinants of postprandial lipemia differ from those of fasting triglycerides: the atherosclerosis risk in communities (ARIC) study. Arterioscler Thromb Vasc Biol 21 (2001) 275-281
2. Steiner G. Triglyceride-rich lipoproteins and atherosclerosis, from fast to feast. Ann Med 25 (1993) 431-435
3. Bansal S., Buring J.E., Rifai N., Mora S., Sacks F.M., and Ridker P.M. Fasting compared with nonfasting triglycerides and risk of cardiovascular events in women. JAMA 298 (2007) 309-316
4. Kolovou G., Anagnostopoulou K., Pavlidis A., et al. Postprandial lipemia in men with metabolic syndrome, hypertensives and healthy subjects. Lipids in Health and Disease 4 (2005) 21
5. Eliasson B., Mero N., Taskinen M.R., and Smith U. The insulin resistance syndrome and postprandial lipid intolerance in smokers. Atherosclerosis 129 (1997) 79-88
6. Chung B.-H., Doran S., Liang P., et al. Alcohol-mediated enhancement of postprandial lipemia: a contributing factor to an increase in plasma HDL and a decrease in risk of cardiovascular disease. Am J Clin Nutr 78 (2003) 391-399
7. Kabagambe E.K., Baylin A., Ruiz-Narvarez E., Rimm E.B., and Campos H. Alcohol intake, drinking patterns and risk of nonfatal acute myocardial infarction in Costa Rica. Am J Clin Nutr 82 (2005) 1336-1345
8. Gronholdt M.L.M., Sillesen H., Wiebe B.M., Laursen H., and Nordestgaard B.G. Increased acute phase reactants are associated with levels of lipoproteins and increased carotid plaque volume. European Journal of Vascular and Endovascular Surgery 21 (2001) 227
9. Lanes R., Paoli M., Carrillo E., Villaroel O., and Palacios A. Peripheral inflammatory and fibrinolytic markers in adolescents with growth hormone deficiency: relation to postprandial dyslipidemia. The Journal of Pediatrics 145 (2004) 657
10. Bradescu O.M., Georgescu M., Ifrim S., Ioacara S., and Ionescu-Tirgoviste C. Meal testing and postprandial state of type 2 diabetic patients with metabolic syndrome. Rom J Intern Med 43 (2005) 97-113
11. Chung C.P., Oeser A., Solus J., et al. Inflammatory mechanisms affecting the lipid profile in patients with systemic lupus erythematosus. J Rheumatol (2007)
12. Borba E.F., Carvalho J.F., and Bonfa E. Mechanisms of dyslipoproteinemias in systemic lupus erythematosus. Clin Dev Immunol 13 (2006) 203-208
13. Genetics of Lipid Lowering Drugs and Diet Network (GOLDN) study. http://wwwbiostatwustledu/goldn/ (Last accessed: March 03, 2008).
14. Corella D., Arnett D.K., Tsai M.Y., et al. The -256T > C polymorphism in the apolipoprotein A-II gene promoter is associated with body mass index and food intake in the genetics of lipid lowering drugs and diet network study. Clin Chem 53 (2007) 1144-1152
15. Kabagambe E.K., Tsai M.Y., Hopkins P.N., et al. Erythrocyte fatty acid composition and the metabolic syndrome: a national heart, lung, and blood institute GOLDN study. Clin Chem 54 (2008) 154-162
16. PROGENI (PROgram for GENetic Interaction). http://wwwbiostatwustledu/progeni/ (Last accessed: March 3, 2008).
17. Tsai M.Y., Hanson N.Q., Straka R.J., et al. Effect of influenza vaccine on markers of inflammation and lipid profile. J Lab Clin Med 145 (2005) 323-327
18. Shen J., Arnett D.K., Peacock J.M., et al. Interleukin 1-beta genetic polymorphisms interact with polyunsaturated fatty acids to modulate risk of the metabolic syndrome. J Nutr 137 (2007) 1846-1851
19. NCI, Diet History Questionnaire, Version 1.0. National Institutes of Health, Applied Research Program, National Cancer Institute. 2007.
20. Matthews D.R., Hosker J.P., Rudenski A.S., Naylor B.A., Treacher D.F., and Turner R.C. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28 (1985) 412-419
21. Hu F.B., Rimm E.B., Stampfer M.J., Ascherio A., Spiegelman D., and Willett W.C. Prospective study of major dietary patterns and risk of coronary heart disease in men. Am J Clin Nutr 72 (2000) 912-921
22. Littell R.C., Milliken G.A., Stroup W.W., Wolfinger R.D., and Schabenberger O. SAS for mixed models. second ed. (2006), SAS, Cary, NC
23. Kenward M.G., and Roger J.H. Small sample inference for fixed effects from restricted maximum likelihood. Biometrics 53 (1997) 983-997
24. Hulea S.A., Olinescu R., Nita S., Crocnan D., and Kummerow F.A. Cigarette smoking causes biochemical changes in blood that are suggestive of oxidative stress: a case-control study. J Environ Pathol Toxicol Oncol 14 (1995) 173-180
25. Ozguner F., Koyu A., and Cesur G. Active smoking causes oxidative stress and decreases blood melatonin levels. Toxicol Ind Health 21 (2005) 21-26
26. Tanriverdi H., Evrengul H., Kuru O., et al. Cigarette smoking induced oxidative stress may impair endothelial function and coronary blood flow in angiographically normal coronary arteries. Circ J 70 (2006) 593-599
27. Aguilo A., Tauler P., Fuentespina E., Tur J.A., Cordova A., and Pons A. Antioxidant response to oxidative stress induced by exhaustive exercise. Physiol Behav 84 (2005) 1